KRAS let-7 LCS6 SNP predicts cetuximab efficacy in KRASwt metastatic colorectal cancer patients: Does treatment combination partner matter?
| Data(s) |
01/02/2011
|
|---|---|
| Identificador | |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Zhang , W , Labonte , M J , Lenz , H-J & LaBonte Wilson , M 2011 , ' KRAS let-7 LCS6 SNP predicts cetuximab efficacy in KRASwt metastatic colorectal cancer patients: Does treatment combination partner matter? ' Annals of oncology : official journal of the European Society for Medical Oncology / ESMO , vol 22 , no. 2 , pp. 484-5 . DOI: 10.1093/annonc/mdq704 |
| Palavras-Chave | #Antibodies, Monoclonal #Antibodies, Monoclonal, Humanized #Antineoplastic Agents #Codon #Colorectal Neoplasms #Genes, ras #Humans #Mutation #Neoplasm Metastasis #Polymorphism, Single Nucleotide |
| Tipo |
article |
